Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386615 · ClinicalTrials.gov registry record
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
A clinical trial of Uterine Fibroid, sponsored by InSightec.
- Recruiting
- Registry status
- 200
- Enrollment target
- 6
- Study locations
NCT05386615 is a study of Uterine Fibroid that is actively recruiting participants, run by InSightec. The registered enrollment target is 200 participants, below the 282-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (29% lower). The trial reports 6 study locations across 3 states.
The verdict
NCT05386615, a study of Uterine Fibroid, is actively recruiting participants, sponsored by InSightec.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Conditions Studied
Interventions
- DEVICE Body System - Functional
Study Locations (6)
Other
- Huashan Hospital Affiliated to Fudan University - Shanghai
- Shanghai No. 1 Hospital - Shanghai
- Shanghai No.1 Hospital - Shanghai
California
- UCLA - Los Angeles
- Stanford University - Stanford
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-02-16 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05386615
The ClinicalTrials.gov registry entry for NCT05386615 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 282-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (29% lower). The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Fibroid appearing as the primary indexed condition, and to 1 intervention - of which Body System - Functional is the first listed.
NCT05386615 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Other, California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05386615 about?
NCT05386615 is a clinical study titled "Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids". The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
What is the current status of trial NCT05386615?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2016-02-16. Estimated completion is 2026-12-31.
What conditions does trial NCT05386615 study?
This clinical trial studies the following conditions: Uterine Fibroid.
What interventions are being tested in trial NCT05386615?
The interventions under investigation include: Body System - Functional (DEVICE).
Who is sponsoring clinical trial NCT05386615?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05386615 being conducted?
This trial has 6 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
RECRUITING · Phase 2
-
Life Study: Lifestyle Intervention in Fibroid Elimination
ACTIVE NOT RECRUITING · NA
-
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings
COMPLETED · NA
-
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
COMPLETED · Phase 3
-
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.